The Efficacy of Radiomics to Predict Tumor Microenvironment Markers and Comprehensive Therapy for Bladder Cancer
CompletedOBSERVATIONAL
Enrollment
1,200
Participants
Timeline
Start Date
May 30, 2023
Primary Completion Date
February 1, 2024
Study Completion Date
February 20, 2024
Conditions
Bladder CancerRadiomicsImmunotherapy
Trial Locations (1)
Unknown
Sun Yat-sen Memorial Hospital, Guangzhou
All Listed Sponsors
lead
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
OTHER
NCT06381895 - The Efficacy of Radiomics to Predict Tumor Microenvironment Markers and Comprehensive Therapy for Bladder Cancer | Biotech Hunter | Biotech Hunter